Company CVAbout Apollo Hospitals Enterprise Ltd. 
Apollo Hospitals Enterprise Ltd.
Large Cap
Hospital
Apollo Hospitals Enterprise Limited (AHEL) is a leading private sector healthcare provider in Asia. It has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies, Primary Care & Diagnostic Clinics. AHEL's Hospitals are situated in Chennai, Hyderabad, Delhi, Ahmedabad, Pune, Chenganur, Coimbatore, Jaipur, Madurai, Anantpur, Nellore, Kurnool, Bhopal, Ranchi, Bilaspur and Bacheli.
Company Coordinates
Company Details
No 19 Bishop Garden, Raja Annamalaipuram Chennai Tamil Nadu : 600028
Registrar Details
Integrated Enterprises (India) Ltd , II Floor , Kences Towers, No 1 Ramakrishna Street, North Usman Road, T Nagar, Chennai
Capital StructureCapital Structure
Present Equity Capital
INR 71.89 Cr
Number of Shares
14.38 Cr
Face Value
INR 5.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
23-Jan-2021
14.38
71.89
4659498
5
Qualified Institutional Placement
24-Jul-2012
13.91
69.56
3276922
5
Conversion of Warrants
24-Jul-2012
13.91
69.56
3276922
5
Conversion of Warrants
07-Jun-2012
13.58
67.92
1381619
5
FCCB
07-Jun-2012
13.58
67.92
1381619
5
FCCB
10-Dec-2011
13.45
67.23
3089242
5
Conversion of Warrants
10-Dec-2011
13.45
67.23
3089242
5
Conversion of Warrants
20-Jul-2011
13.14
65.69
6666666
5
QIB Equity Shares
20-Jul-2011
13.14
65.69
6666666
5
QIB Equity Shares
09-Dec-2010
12.47
62.36
1140992
5
FCCB
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
FIIs
Pledged Promoter Holdings
8.5761
Mutual Funds
Held by 349 Schemes (16.48%)
FIIs
Held by 1184 FIIs (44.2%)
Promoter with highest holding
M/s. Pcr Investments Ltd (18.93%)
Highest Public shareholder
Kotak Funds-India Midcap Fund (10.19%)
Individual Investors Holdings
4.44%
Board of Directors
Management
Designation
Remuneration
Prathap C Reddy
Executive Chairman
18.11 cr
Preetha Reddy
Executive Vice Chairperson
6.75 cr
Suneeta Reddy
Managing Director
6.72 cr
Sangita Reddy
Joint Managing Director
6.54 cr
Shobana Kamineni
Executive Vice Chairperson
6.34 cr
S M Krishnan
Senior Vice President & CS
0
Vinayak Chatterjee
Independent Director
49.0 lacs
Murali Doraiswamy
Independent Director
43.0 lacs
V Kavitha Dutt
Independent Director
37.0 lacs
M B N Rao
Lead Independent Director
47.0 lacs
Som Mittal
Independent Director
36.0 lacs
Rama Bijapurkar
Independent Director
31.0 lacs
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Raw Materials Consumed
2248.4
0%
Raw Materials Consumed
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Income from Clinical Trials
5.11
0.06%
Income from Clinical Trials
Income from Clinical Trials
Stock DNARevenue and Profits:
Net Sales:
6,304 Cr
(Quarterly Results - Sep 2025)
Net Profit:
477 Cr
Hospital
INR 103,309 Cr (Large Cap)
62.00
63
0.26%
0.53
18.39%
11.36
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
